Hochschulschrift
Molecular mechanism of class I cytokine receptor activation and their dysregulation by oncogenic mutations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
IV, 102 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Universität Osnabrück, Dissertation, 2020
- Ereignis
-
Veröffentlichung
- (wo)
-
Osnabrück
- (wann)
-
November 2020
- Urheber
-
Hafer, Maximilian
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Hafer, Maximilian
Entstanden
- November 2020
Ähnliche Objekte (12)
Oncogenic potential of rare RRAS2 mutations
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Research in practice : therapeutic targeting of oncogenic GNAQ mutations in uveal melanoma
Allosteric activation mechanism of a human oncogenic chromatin remodeler ALC1
Oncogenic KrasG12D causes myeloproliferation in leukaemia via NLRP3 inflammasome activation
Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone
Characterization and localization of intracellular signals emanating from an oncogenic mutant of the cytokine receptor Gp130
Effects of Small Molecules and Cytokine Signalling on NLRP3 Inflammasome Activation
Spatiotemporal dynamics of assembly and activation of class II cytokine receptors
Germline biallelic PIK3CG mutations in a multifaceted immunodeficiency with immune dysregulation : : letter to the editor
Unraveling the activation mechanism of taspase1 which controls the oncogenic AF4–MLL fusion protein
Oncogenic JAK2 activation causes PD-L1 expression, sensitizing myeloproliferative neoplasms to immune checkpoint inhibition
Oncogenic potential of rare RRAS2 mutations
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Research in practice : therapeutic targeting of oncogenic GNAQ mutations in uveal melanoma
Allosteric activation mechanism of a human oncogenic chromatin remodeler ALC1
Oncogenic KrasG12D causes myeloproliferation in leukaemia via NLRP3 inflammasome activation
Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone
Characterization and localization of intracellular signals emanating from an oncogenic mutant of the cytokine receptor Gp130
Effects of Small Molecules and Cytokine Signalling on NLRP3 Inflammasome Activation
Spatiotemporal dynamics of assembly and activation of class II cytokine receptors
Germline biallelic PIK3CG mutations in a multifaceted immunodeficiency with immune dysregulation : : letter to the editor
Unraveling the activation mechanism of taspase1 which controls the oncogenic AF4–MLL fusion protein
Oncogenic JAK2 activation causes PD-L1 expression, sensitizing myeloproliferative neoplasms to immune checkpoint inhibition
Oncogenic potential of rare RRAS2 mutations
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Research in practice : therapeutic targeting of oncogenic GNAQ mutations in uveal melanoma
Allosteric activation mechanism of a human oncogenic chromatin remodeler ALC1
Oncogenic KrasG12D causes myeloproliferation in leukaemia via NLRP3 inflammasome activation
Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone
Characterization and localization of intracellular signals emanating from an oncogenic mutant of the cytokine receptor Gp130
Effects of Small Molecules and Cytokine Signalling on NLRP3 Inflammasome Activation
Spatiotemporal dynamics of assembly and activation of class II cytokine receptors
Germline biallelic PIK3CG mutations in a multifaceted immunodeficiency with immune dysregulation : : letter to the editor
Unraveling the activation mechanism of taspase1 which controls the oncogenic AF4–MLL fusion protein